Antibodies against the C-terminus of apoA-1 are inversely associated with cholesterol efflux capacity and HDL metabolism in subjects with and without type 2 diabetes mellitus

DULLAART, Robin P F et al. Antibodies against the C-terminus of apoA-1 are inversely associated with cholesterol efflux capacity and HDL metabolism in subjects with and without type 2 diabetes mellitus. In: International Journal of Molecular Sciences, 2019, vol. 20, n° 3, p. E732. doi: 10.3390/ijms20030732

Article (Published version)

CC BY

Identifiers

PID : unige:121603
DOI : 10.3390/ijms20030732
PMID : 30744100

ISSN of the journal1661-6596

299views

161downloads

Creation08/14/2019 3:03:00 PM

First validation08/14/2019 3:03:00 PM

Update time03/15/2023 5:51:23 PM

Status update03/15/2023 5:51:22 PM

Last indexation02/12/2024 11:42:13 AM

Archive ouverte UNIGE

Antibodies against the C-terminus of apoA-1 are inversely associated with cholesterol efflux capacity and HDL metabolism in subjects with and without type 2 diabetes mellitus

We determined relationships of cholesterol efflux capacity (CEC), plasma cholesterol esterification (EST) and cholesteryl ester transfer (CET) with anti-c-terminus apoA-1 (Ac-terAA1) and anti-apolipoprotein (apo)-1 (AAA1) autoantibodies in subjects with and without Type 2 diabetes mellitus (T2D).

Technical informations